15 mayo 2016 año - Daily treatment with Vismodegib (Hh
antagonist) downregulated Hh target
genes Gli1, Hhip and Ptch1 and caused
significant reduction of tumour volume
and tumour growth delay.
Descripción:
Antagonizing the Hedgehog Pathway with Vismodegib Impairs Malignant Pleural Mesothelioma Growth In Vivo by Affecting Stroma.
Añadido al timeline:
fecha:
15 mayo 2016 año
Ahora mismo
~ 8 years ago